| Nov 13 |
Bearish: Analysts Just Cut Their Assembly Biosciences, Inc. (NASDAQ:ASMB) Revenue and EPS estimates
|
| Nov 8 |
Assembly Biosciences GAAP EPS of -$1.51, revenue of $6.85M
|
| Nov 7 |
Assembly Biosciences: Q3 Earnings Snapshot
|
| Nov 7 |
Assembly Biosciences Reports Third Quarter 2024 Financial Results and Recent Updates
|
| Oct 2 |
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year?
|
| Sep 23 |
Assembly Biosciences' Investigational Herpes Treatment Shows Antiviral Efficacy, Safety In Healthy Participants
|
| Sep 23 |
Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366
|
| Sep 16 |
Is Assembly Biosciences (ASMB) Stock Outpacing Its Medical Peers This Year?
|
| Aug 30 |
Is Sensus Healthcare (SRTS) Stock Outpacing Its Medical Peers This Year?
|
| Aug 29 |
Individual investors in Assembly Biosciences, Inc. (NASDAQ:ASMB) are its biggest bettors, and their bets paid off as stock gained 14% last week
|
